U6 snRNA biogenesis phosphodiesterase 1
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The USB1 gene provides instructions for making an enzyme that functions as an RNA exonuclease. RNA exonucleases cut off (cleave) building blocks called nucleotides one at a time from molecules of RNA (a chemical cousin of DNA). This process helps stabilize the RNA and protects it from damage.
Video picks for GenesVideo library
Normal function
The USB1 gene provides instructions for making an enzyme that functions as an RNA exonuclease. RNA exonucleases cut off (cleave) building blocks called nucleotides one at a time from molecules of RNA (a chemical cousin of DNA). This process helps stabilize the RNA and protects it from damage.
Specifically, the USB1 enzyme protects a small RNA molecule called U6, which is an essential component of a complex called a spliceosome. The USB1 enzyme also helps transport (chaperones) U6 to the spliceosome and helps it attach (bind) to the proteins in the complex. Spliceosomes process RNA molecules called messenger RNAs (mRNAs) by recognizing and removing regions known as introns and splicing the mRNA molecules back together to provide the blueprint for making proteins.
Different versions (isoforms) of the USB1 enzyme are produced in different tissues, where they play various roles. In blood-forming tissues, the USB1 enzyme is thought to be important for the maturation of neutrophils. Neutrophils are a type of white blood cell involved in the immune system. In the skin, the USB1 enzyme is found in pigment-producing cells (melanocytes), cells in the outer layer of the skin called keratinocytes, and structural cells called fibroblasts. Its role in the function of these cells is unknown.
Conditions referring to this gene or chromosome
Other names
C16orf57
chromosome 16 open reading frame 57
hMPN1: mutated in PN1
U six biogenesis 1
U6 small nuclear RNA biogenesis phosphodiesterase 1
U6 snRNA biogenesis 1
Patient picks for Genes

PID Q&A
Does PID cause bleeding?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

Meningitis Q&A
How do you get bacterial meningitis?
Dr Sarah Jarvis MBE Neisseria meningitidis (meningococcus) is a common germ (bacterium), living harmlessly in the nose and throat of about 1 in 4 people. These people are called carriers. This bacterium does not survive outside the body. Close contact is needed to pass it on to others, such as intimate kissing, coughing or sneezing near to others. For more information on meningitis, go to [https://patient.info/health/meningitis-leaflet](https://patient.info/health/meningitis-leaflet)
by Dr Sarah Jarvis

PID Q&A
How do you diagnose PID?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

UTI Q&A
Can you get a UTI on your period?
Dr Sarah Jarvis MBE Lower urinary tract symptoms (LUTS) are common in women of all ages, especially between the ages of 40-60. For many women, the symptoms come and go. But for some women, the symptoms are ongoing and interfere with normal life. [https://patient.info/health/lower-urinary-tract-symptoms-in-women-luts#nav-1](https://patient.info/health/lower-urinary-tract-symptoms-in-women-luts#nav-1)
by Dr Sarah Jarvis

UTI Q&A
Can you get a UTI when pregnant?
Dr Sarah Jarvis MBE Lower urinary tract symptoms (LUTS) are common in women of all ages, especially between the ages of 40-60. For many women, the symptoms come and go. But for some women, the symptoms are ongoing and interfere with normal life. [https://patient.info/health/lower-urinary-tract-symptoms-in-women-luts#nav-1](https://patient.info/health/lower-urinary-tract-symptoms-in-women-luts#nav-1)
by Dr Sarah Jarvis

Miscarriage Q&A
How much do you bleed when you have a miscarriage?
Dr Sarah Jarvis MBE Many women experience some bleeding in early pregnancy. About 1 in 5 recognised pregnancies end in miscarriage. Most are caused by a one-off fault in the genes. Always tell your doctor if you have vaginal bleeding when you are pregnant. For more information on miscarriages, go to [https://patient.info/health/miscarriage-and-bleeding-in-early-pregnancy](https://patient.info/health/miscarriage-and-bleeding-in-early-pregnancy)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Down's syndrome screening
This causes the typical features of Down's syndrome. See the separate leaflet called Down's syndrome for more details Down's syndrome. What increases your chance of having a b... The chromosomes in their blood can then be examined to look for an extra chromosome 21. The rest of this leaflet concentrates on screening for Down's syndrome and the.

Patient information leaflet
Kidney biopsy
A kidney biopsy involves taking a small sample of tissue from the kidney. Cells from the kidney can then be looked at in detail. It is used to diagnose and monitor certain conditions. Note : the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. Always follow the.

Patient information leaflet
Alpha-blockers
Alpha-blockers are medicines that are mainly used to treat high blood pressure (hypertension) and problems with passing urine in men who have enlargement of the prostate gland. Prostate gland enlargement is also called benign prostatic hyperplasia (BPH). What are alpha-blockers used for. In the past, some alpha-blockers were also used to treat.

Patient information leaflet
Wilson's disease
Wilson's disease is a genetic disorder in which copper builds up in the body, mainly in the liver and brain. Without any treatment, the build-up of copper can cause serious symptoms. Treatment is with medication to remove the excess copper and/or to prevent a further build-up of copper. What is Wilson's disease. Wilson's disease is a condition.

Patient information leaflet
Giant Cell Arteritis
Prompt treatment aims to prevent serious complications such as severe sight impairment which can occur soon after the disease starts. What is giant cell arteritis. Giant cell arteritis (GCA), also known as temporal arteritis, is a condition which causes inflammation on the inside of some blood vessels (arteries). It is called 'giant cell' because.

Patient information leaflet
Oral bronchodilators
What is a bronchodilator. Bronchodilators are medicines that are used to treat breathing problems in people with lung diseases such as asthma Asthma and chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease. They help to relieve symptoms such as coughing, wheezing and shortness of breath. Bronchodilators are usually.
Further reading and references
- U6 snRNA biogenesis phosphodiesterase 1; MedlinePlus, National Library of Medicine.
- Colombo EA, Bazan JF, Negri G, Gervasini C, Elcioglu NH, Yucelten D, Altunay I, Cetincelik U, Teti A, Del Fattore A, Luciani M, Sullivan SK, Yan AC, Volpi L, Larizza L. Novel C16orf57 mutations in patients with Poikiloderma with Neutropenia: bioinformatic analysis of the protein and predicted effects of all reported mutations. Orphanet J Rare Dis. 2012 Jan 23;7:7. doi: 10.1186/1750-1172-7-7.
- Didychuk AL, Montemayor EJ, Carrocci TJ, DeLaitsch AT, Lucarelli SE, Westler WM, Brow DA, Hoskins AA, Butcher SE. Usb1 controls U6 snRNP assembly through evolutionarily divergent cyclic phosphodiesterase activities. Nat Commun. 2017 Sep 8;8(1):497. doi: 10.1038/s41467-017-00484-w.
- Hilcenko C, Simpson PJ, Finch AJ, Bowler FR, Churcher MJ, Jin L, Packman LC, Shlien A, Campbell P, Kirwan M, Dokal I, Warren AJ. Aberrant 3' oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia. Blood. 2013 Feb 7;121(6):1028-38. doi: 10.1182/blood-2012-10-461491. Epub 2012 Nov 27.
- Mroczek S, Dziembowski A. U6 RNA biogenesis and disease association. Wiley Interdiscip Rev RNA. 2013 Sep-Oct;4(5):581-92. doi: 10.1002/wrna.1181. Epub 2013 Jun 14.
- Mroczek S, Krwawicz J, Kutner J, Lazniewski M, Kucinski I, Ginalski K, Dziembowski A. C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3' end modification. Genes Dev. 2012 Sep 1;26(17):1911-25. doi: 10.1101/gad.193169.112. Epub 2012 Aug 16.
- Negri G, Crescenzi B, Colombo EA, Fontana L, Barba G, Arcioni F, Gervasini C, Mecucci C, Larizza L. Expanding the role of the splicing USB1 gene from Poikiloderma with Neutropenia to acquired myeloid neoplasms. Br J Haematol. 2015 Nov;171(4):557-65. doi: 10.1111/bjh.13651. Epub 2015 Aug 25.
- Shchepachev V, Azzalin CM. The Mpn1 RNA exonuclease: cellular functions and implication in disease. FEBS Lett. 2013 Jun 27;587(13):1858-62. doi: 10.1016/j.febslet.2013.05.005. Epub 2013 May 15.
- Volpi L, Roversi G, Colombo EA, Leijsten N, Concolino D, Calabria A, Mencarelli MA, Fimiani M, Macciardi F, Pfundt R, Schoenmakers EF, Larizza L. Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene. Am J Hum Genet. 2010 Jan;86(1):72-6. doi: 10.1016/j.ajhg.2009.11.014. Epub 2009 Dec 10.
- Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I. Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome. Hum Mol Genet. 2010 Nov 15;19(22):4453-61. doi: 10.1093/hmg/ddq371. Epub 2010 Sep 3.
- Wang L, Clericuzio C, Larizza L, Concolino D. Poikiloderma with Neutropenia. 2017 Oct 26 [updated 2024 Feb 22]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK459118/
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

